XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Marketable securities (Tables)
3 Months Ended
Mar. 31, 2024
Marketable Securities  
Schedule of marketable securities
            
   As of March 31, 2024
   Amortized Cost  Gross Unrealized Gains  Gross Unrealized Losses  Fair Value
             
Marketable Securities                    
Corporate Bonds  $1,002,050   $12,697   $(32,143)  $982,604 
Total Marketable Securities  $1,002,050   $12,697   $(32,143)  $982,604 

 

   As of 12/31/2023
   Amortized Cost 

Gross Unrealized

Gains

 

Gross

Unrealized

Losses

  Fair Value
             
Marketable Securities                    
Corporate Bonds  $4,473,033   $50,878   $(60,969)  $4,462,942 
Total Marketable Securities  $4,473,033   $50,878   $(60,969)  $4,462,942 
Schedule of assets and liabilities measured at fair value
                               
    Fair Value Measurements Using
    Balance as of
March 31, 2024
  Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
  Significant Other
Observable Inputs
(Level 2)
  Significant
Nonobservable
(Level 3)
Marketable securities:                                
                                 
Corporate Bonds   $ 982,604     $     $ 982,604     $  
                                 
Total marketable securities   $ 982,604     $     $ 982,604     $  

 

    Fair Value Measurements Using
    Balance as of
December 31, 2023
  Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
  Significant Other
Observable Inputs
(Level 2)
  Significant
Non-observable Inputs
(Level 3)
Marketable securities:                                
Corporate Bonds   $ 4,462,942     $     $ 4,462,942     $  
                         
Total marketable securities   $ 4,462,942     $     $ 4,462,942     $  

 

The Company’s investments in corporate bonds, commercial paper and certificates of deposits are measured based on quotes from market makers for similar items in active markets.